EYEGATE PHARMACEUTICALS INC's ticker is EYEGW and the CUSIP is 30233M115. A total of 5 filers reported holding EYEGATE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,000 | -62.5% | 20,604 | -56.1% | 0.00% | -100.0% |
| Q3 2016 | $16,000 | +700.0% | 46,968 | -12.8% | 0.00% | – |
| Q2 2016 | $2,000 | -95.9% | 53,893 | -17.6% | 0.00% | -100.0% |
| Q1 2016 | $49,000 | -62.6% | 65,393 | -62.5% | 0.00% | -71.4% |
| Q4 2015 | $131,000 | -35.8% | 174,150 | -12.9% | 0.01% | -12.5% |
| Q3 2015 | $204,000 | – | 200,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 137,092 | $7,000 | 0.00% |
| CVI Holdings, LLC | 12,900 | $0 | 0.00% |
| UBS Group AG | 4,300 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |